Duo Fight For Fingolimod Share In Canada

Patent-Infringement Actions Were Discontinued

 
• By Aidan Fry
  
Bears
Teva and Pharmascience are battling for share in Canada's fingolimod market • Source: Shutterstock

More from Products

More from Generics Bulletin